Stockscreener 앱 받기
5.2904
2.03%
-0.1096
전일 마감가:
$5.40
열려 있는:
$5.1818
하루 거래량:
1,265
Relative Volume:
0.09
시가총액:
$190.23M
수익:
-
순이익/손실:
$-25.50M
주가수익비율:
-6.8706
EPS:
-0.77
순현금흐름:
$-30.10M
1주 성능:
-3.64%
1개월 성능:
-9.41%
6개월 성능:
+82.70%
1년 성능:
+84.98%
1일 변동 폭
$5.1818
$5.2904
1주일 범위
$5.1818
$5.673
52주 변동 폭
$2.20
$6.1999
Eupraxia Pharmaceuticals Inc Stock (EPRX) Company Profile
EPRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EPRX
Eupraxia Pharmaceuticals Inc
|
5.2904 | 189.64M | 0 | -25.50M | -30.10M | -0.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.51 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.00 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
385.55 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
663.64 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.11 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Eupraxia Pharmaceuticals Inc Stock (EPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-06-26 | 개시 | H.C. Wainwright | Buy |
| 2025-06-16 | 개시 | Canaccord Genuity | Speculative Buy |
| 2025-02-21 | 개시 | Craig Hallum | Buy |
| 2024-11-14 | 개시 | Rodman & Renshaw | Buy |
Eupraxia Pharmaceuticals Inc 주식(EPRX)의 최신 뉴스
Using Bollinger Bands to evaluate Eupraxia Pharmaceuticals Inc.Long-Term Investment Strategy Impact Analysis - Newser
Using R and stats models for Eupraxia Pharmaceuticals Inc. forecastingChart-Based Entry Confirmation for Beginners - Newser
Eupraxia Pharmaceuticals Inc. stock daily chart insightsFree Step-by-Step Stock Investment Guide - Newser
Is it the right time to buy Eupraxia Pharmaceuticals Inc. stockMarket Forecast Opportunities For Every Investor - jammulinksnews.com
Is Eupraxia Pharmaceuticals Inc. forming a reversal patternHigh Confidence Strategy with Trend Alignment - Newser
Where are the Opportunities in (EPRX) (EPRX:CA) - news.stocktradersdaily.com
Why Eupraxia Pharmaceuticals Inc. stock attracts strong analyst attentionFree Entry Alert With Low Drawdown Strategy - Newser
Signal strength of Eupraxia Pharmaceuticals Inc. stock in tech scannersAI Entry Timing Prediction for Swing Traders - Newser
What high frequency data says about Eupraxia Pharmaceuticals Inc.Free Value Investing Picks With Stability - Newser
Eupraxia Pharmaceuticals (OTCMKTS:EPRXF) Shares Down 0.9% – Here’s What Happened - Defense World
What makes Eupraxia Pharmaceuticals Inc. stock price move sharplySector-Wise Equity Performance Trend Forecast - Newser
Is Eupraxia Pharmaceuticals Inc. Stock a Good Fit for Conservative InvestorsNews Based Entry Opportunity Alerts Detected - metal.it
How Interest Rate Changes Impact Eupraxia Pharmaceuticals Inc. Stock PerformanceGrowth Watchlist for Long Term Positioning - Newser
Is Eupraxia Pharmaceuticals Inc. stock a growth or value playBuy and Exit Strategy Based on Momentum - Newser
Published on: 2025-07-29 11:23:51 - metal.it
Why did EPRX's Q4 2024 earnings report show no surprise? - AInvest
Published on: 2025-07-29 10:20:51 - metal.it
Can Eupraxia Pharmaceuticals Inc. Overcome Bearish SentimentDay Trading Signals With High Precision Reviewed - metal.it
Is Eupraxia Pharmaceuticals Inc. forming a bottoming baseWeekly Price Target Forecast and Alerts - Newser
How volatile is Eupraxia Pharmaceuticals Inc. stock compared to the marketAchieve consistent double-digit returns - jammulinksnews.com
Cantor Fitzgerald Forecasts EPRX FY2025 Earnings - Defense World
What institutional investors are buying Eupraxia Pharmaceuticals Inc. stockFree Investment Risk Control - jammulinksnews.com
Why is Eupraxia Pharmaceuticals Inc. stock attracting strong analyst attentionConsistent double returns - jammulinksnews.com
How does Eupraxia Pharmaceuticals Inc. generate profit in a changing economyGet professional guidance for market timing - jammulinksnews.com
Eupraxia Pharmaceuticals Inc. Earnings Report Breakdown: What Investors Should KnowHigh Return Setup Scanner - Newser
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Receives $11.00 Average Target Price from Analysts - Defense World
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Coverage Initiated at Cantor Fitzgerald - Defense World
Is Eupraxia Pharmaceuticals Inc. a good long term investmentFree Trend-Following Techniques - PrintWeekIndia
Eupraxia Pharmaceuticals Inc. Stock Analysis and ForecastFree Stock Chart Pattern Guide - Autocar Professional
Eupraxia Pharmaceuticals Inc (EPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.11%
0.24%
자본화:
|
볼륨(24시간):